Inventor

Donald C. Monkhouse

Inventor
Radnor, PA, US

Overview

18→
Patents
1976–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 18 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
B33YAdditive manufacturing, i.e. manufacturing of three-dimensional [3d] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3d printing, stereolithography or selective laser sintering22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A61FFilters implantable into blood vessels7%
B29CShaping or joining of plastics7%
A61JContainers specially adapted for medical or pharmaceutical purposes4%
A61LMethods or apparatus for sterilising materials or objects in general2%
B29LIndexing scheme associated with subclass b29c, relating to particular articles2%
C04BLime, magnesia2%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
10,420,785Rapidly dispersible dosage form of topiramate20199,669,009'Rapid disperse dosage form containing levetiracetam'20179,492,380'Rapidly dispersible dosage form of topiramate'20169,463,160'Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same'20169,339,489'Rapid disperse dosage form containing levetiracetam'20169,114,072'Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same'20158,828,411'Dosage forms and methods of use thereof'20147,875,290'Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form'20117,276,252'Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form'20077,122,057'Method and apparatus for engineered regenerative biostructures such as hydroxyapatite substrates for bone healing applications'20066,547,994'Rapid prototyping and manufacturing process'20036,514,518'Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof'20036,471,992'Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same'20026,280,771'Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof'20014,946,838'Crystalline anhydrous aztreonam'19904,344,940'Steroid formulation containing dipotassium EDTA'19823,954,787'Stabilized E-series prostaglandins'19763,952,004'Stabilized E-series prostaglandins'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976Based in Waterford, CT, US· patent location history
1982–1990Based in Princeton, NJ, US· patent location history
2001–2016Patents assigned to MASSACHUSETTS INST TECHNOLOGY (6)· patent assignee history
2001–2003Patents assigned to THERICS INC (4)· patent assignee history
2001–2019Based in Radnor, PA, US· patent location history
2014–2017Patents assigned to APRECIA PHARMACEUTICALS CO (4)· patent assignee history
2014–2016Patents assigned to MONKHOUSE DONALD C (4)· patent assignee history
2015–2016Patents assigned to KUMAR SANDEEP (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MASSACHUSETTS INST TECHNOLOGY62001–2016
APRECIA PHARMACEUTICALS CO42014–2017
MONKHOUSE DONALD Cself42014–2016
THERICS INC42001–2003
KUMAR SANDEEP22015–2016
Locations
LocationPatentsSpan
Radnor, Pennsylvania, US142001–2019
Princeton, New Jersey, US21982–1990
Waterford, CT, US21976